These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1589 related items for PubMed ID: 26923792

  • 1. Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review.
    Alcocer L.
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):171-82. PubMed ID: 26923792
    [Abstract] [Full Text] [Related]

  • 2. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
    Alamneh EA, Chalmers L, Bereznicki LR.
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063
    [Abstract] [Full Text] [Related]

  • 3. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.
    Lip GY, Mitchell SA, Liu X, Liu LZ, Phatak H, Kachroo S, Batson S.
    Int J Cardiol; 2016 Feb 01; 204():88-94. PubMed ID: 26655548
    [Abstract] [Full Text] [Related]

  • 4. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
    Di Lullo L, Ronco C, Cozzolino M, Russo D, Russo L, Di Iorio B, De Pascalis A, Barbera V, Galliani M, Vitaliano E, Campana C, Santoboni F, Bellasi A.
    Thromb Res; 2017 Jul 01; 155():38-47. PubMed ID: 28482261
    [Abstract] [Full Text] [Related]

  • 5. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.
    Adv Ther; 2012 Jun 01; 29(6):491-507. PubMed ID: 22684583
    [Abstract] [Full Text] [Related]

  • 6. Renal Function Considerations for Stroke Prevention in Atrial Fibrillation.
    Fanikos J, Burnett AE, Mahan CE, Dobesh PP.
    Am J Med; 2017 Sep 01; 130(9):1015-1023. PubMed ID: 28502818
    [Abstract] [Full Text] [Related]

  • 7. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW, Barillari G.
    J Clin Pharm Ther; 2014 Apr 01; 39(2):118-35. PubMed ID: 24383983
    [Abstract] [Full Text] [Related]

  • 8. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
    Kimachi M, Furukawa TA, Kimachi K, Goto Y, Fukuma S, Fukuhara S.
    Cochrane Database Syst Rev; 2017 Nov 06; 11(11):CD011373. PubMed ID: 29105079
    [Abstract] [Full Text] [Related]

  • 9. Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.
    Kanai Y, Oguro H, Tahara N, Matsuda H, Takayoshi H, Mitaki S, Onoda K, Yamaguchi S.
    J Stroke Cerebrovasc Dis; 2018 Feb 06; 27(2):338-345. PubMed ID: 29033229
    [Abstract] [Full Text] [Related]

  • 10. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
    Lee SI, Sayers M, Lip GY, Lane DA.
    Int J Clin Pract; 2015 Nov 06; 69(11):1341-8. PubMed ID: 26234557
    [Abstract] [Full Text] [Related]

  • 11. Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies.
    Li G, Lip GYH, Holbrook A, Chang Y, Larsen TB, Sun X, Tang J, Mbuagbaw L, Witt DM, Crowther M, Thabane L, Levine MAH.
    Eur J Epidemiol; 2019 Feb 06; 34(2):173-190. PubMed ID: 29948370
    [Abstract] [Full Text] [Related]

  • 12. Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials.
    Loffredo L, Perri L, Violi F.
    Dig Liver Dis; 2015 May 06; 47(5):429-31. PubMed ID: 25732432
    [Abstract] [Full Text] [Related]

  • 13. Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale.
    Xian Y, Hernandez AF, Harding T, Fonarow GC, Bhatt DL, Suter RE, Khan Y, Schwamm LH, Peterson ED.
    Am Heart J; 2016 Dec 06; 182():28-35. PubMed ID: 27914497
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis.
    Skjøth F, Larsen TB, Rasmussen LH, Lip GY.
    Thromb Haemost; 2014 May 05; 111(5):981-8. PubMed ID: 24577485
    [Abstract] [Full Text] [Related]

  • 15. Facing real-life with direct oral anticoagulants in patients with nonvalvular atrial fibrillation: outcomes from the first observational and prospective study in a Spanish population.
    Cerdá M, Cerezo-Manchado JJ, Johansson E, Martínez F, Fernández M, Varela A, Rodríguez S, Bosch F, Santamaría A.
    J Comp Eff Res; 2019 Feb 05; 8(3):165-178. PubMed ID: 30654626
    [Abstract] [Full Text] [Related]

  • 16. Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of Bleeding.
    Hospodar AR, Smith KJ, Zhang Y, Hernandez I.
    Am J Cardiovasc Drugs; 2018 Aug 05; 18(4):317-325. PubMed ID: 29740750
    [Abstract] [Full Text] [Related]

  • 17. Non-vitamin K Oral Anticoagulants Versus Warfarin for Patients with Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights.
    Kumana CR, Cheung BM, Siu DC, Tse HF, Lauder IJ.
    Cardiovasc Ther; 2016 Apr 05; 34(2):100-6. PubMed ID: 26727005
    [Abstract] [Full Text] [Related]

  • 18. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY, Larsen TB, Skjøth F, Rasmussen LH.
    J Am Coll Cardiol; 2012 Aug 21; 60(8):738-46. PubMed ID: 22575324
    [Abstract] [Full Text] [Related]

  • 19. Indirect Comparison of Novel Oral Anticoagulants in Women with Nonvalvular Atrial Fibrillation.
    Moseley A, Doukky R, Williams KA, Jaffer AK, Volgman AS.
    J Womens Health (Larchmt); 2017 Mar 21; 26(3):214-221. PubMed ID: 27870603
    [Abstract] [Full Text] [Related]

  • 20. Direct oral anticoagulants: An update.
    Franco Moreno AI, Martín Díaz RM, García Navarro MJ.
    Med Clin (Barc); 2018 Sep 14; 151(5):198-206. PubMed ID: 29295790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.